Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 27,005 |
|
|||||
| News | - | ||||||
| Day High | 13.00 | Low High |
|||||
| Day Low | 11.25 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Curis Inc | CRIS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.80 | -6.35% | 11.80 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.66 | 11.25 | 13.00 | 11.80 | 12.60 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 582 | 27,005 | $ 11.98 | $ 323,518 | - | 3.80 - 18.526 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:51:13 | 10 | $ 12.27 | USD |
Curis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 69.84M | 5.89M | - | 10.02M | -47.41M | -8.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Curis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRIS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.31 | 16.80 | 11.25 | 13.93 | 34,479 | -4.51 | -27.65% |
| 1 Month | 14.97 | 16.99 | 11.25 | 14.81 | 17,673 | -3.17 | -21.18% |
| 3 Months | 9.99 | 17.49 | 9.04 | 13.52 | 26,836 | 1.81 | 18.12% |
| 6 Months | 6.63 | 17.49 | 5.70 | 10.77 | 63,012 | 5.17 | 77.98% |
| 1 Year | 17.004 | 18.526 | 3.80 | 12.98 | 148,586 | -5.20 | -30.60% |
| 3 Years | 264.412 | 312.00 | 3.80 | 68.51 | 1,277,919 | -252.61 | -95.54% |
| 5 Years | 36.20 | 348.00 | 3.80 | 96.87 | 1,570,540 | -24.40 | -67.40% |
Curis Description
| Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. |
